top of page
FDA


FDA’s New Lens on AI/ML Devices
Artificial intelligence and machine learning (AI/ML) are no longer “future trends” in Medtech, they are here, and the FDA is moving quickly to adapt. In 2023 and 2024 alone, dozens of AI/ML-enabled devices received FDA clearance, spanning diagnostics, imaging, clinical decision support, and digital therapeutics (for example, Medtronic’s AccuRhythm AI for cardiac monitoring and Aidoc’s AI triage tool for rib fractures). We’re well past the era of experimental approvals, this i
Nathan Piland
Aug 28, 20252 min read
bottom of page